Figure 1From: Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)The percentage of change in the lipid parameters is different in cases with a body mass index above 25 kg/m2 compared to the response observed in lean individuals during treatment with ciprofibrate and diet.Back to article page